+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PTA Balloon Catheters - Medical Devices Pipeline Assessment, 2020

  • PDF Icon

    Report

  • 146 Pages
  • October 2020
  • Region: Global
  • GlobalData
  • ID: 5180224
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
Summary

The publisher's Medical Devices sector report, “PTA Balloon Catheters-Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the PTA Balloon Catheters pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

PTA Balloon Catheters segment includes Standard Balloon Catheters and PTA Peripheral DEB Catheters. A PTA Peripheral DCB Catheter is a drug-coated percutaneous transluminal angioplasty (PTA) balloon intended to prevent restenosis, or restenosis of the peripheral arteries. Standard Balloon Catheters are used to open up the arteries that are blocked by plaque build-up (atherosclerosis).

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the PTA Balloon Catheters under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of PTA Balloon Catheters and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry

Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of PTA Balloon Catheters under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents
2 Introduction
2.1 PTA Balloon Catheters Overview
3 Products under Development
3.1 PTA Balloon Catheters-Pipeline Products by Stage of Development
3.2 PTA Balloon Catheters-Pipeline Products by Segment
3.3 PTA Balloon Catheters-Pipeline Products by Territory
3.4 PTA Balloon Catheters-Pipeline Products by Regulatory Path
3.5 PTA Balloon Catheters-Pipeline Products by Estimated Approval Date
3.6 PTA Balloon Catheters-Ongoing Clinical Trials
4 PTA Balloon Catheters-Pipeline Products under Development by Companies
4.1 PTA Balloon Catheters Companies-Pipeline Products by Stage of Development
4.2 PTA Balloon Catheters-Pipeline Products by Stage of Development
5 PTA Balloon Catheters Companies and Product Overview6 PTA Balloon Catheters-Recent Developments7 Appendix
List of Tables
Table 1: PTA Balloon Catheters-Pipeline Products by Stage of Development
Table 2: PTA Balloon Catheters-Pipeline Products by Segment
Table 3: PTA Balloon Catheters-Pipeline Products by Territory
Table 4: PTA Balloon Catheters-Pipeline Products by Regulatory Path
Table 5: PTA Balloon Catheters-Pipeline Products by Estimated Approval Date
Table 6: PTA Balloon Catheters-Ongoing Clinical Trials
Table 7: PTA Balloon Catheters Companies-Pipeline Products by Stage of Development
Table 8: PTA Balloon Catheters-Pipeline Products by Stage of Development
Table 9: Andramed GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Zero-Profile PTA Balloon-Product Status
Table 11: Zero-Profile PTA Balloon-Product Description
Table 12: AnGes Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 13: NF-kB Decoy Oligo Coated PTA Balloon Catheter-Product Status
Table 14: NF-kB Decoy Oligo Coated PTA Balloon Catheter-Product Description
Table 15: AngioCure, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 16: AngioCure TOP-C Smart Balloon Catheter-Product Status
Table 17: AngioCure TOP-C Smart Balloon Catheter-Product Description
Table 18: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 19: Drug Coated Balloon-Below-The-Knee (BTK)-Product Status
Table 20: Drug Coated Balloon-Below-The-Knee (BTK)-Product Description
Table 21: High Pressure Balloon-Venous Disease-Product Status
Table 22: High Pressure Balloon-Venous Disease-Product Description
Table 23: Next Generation 0.018” Balloon-Product Status
Table 24: Next Generation 0.018” Balloon-Product Description
Table 25: Ranger Drug-Coated Balloon-Product Status
Table 26: Ranger Drug-Coated Balloon-Product Description
Table 27: Boston Scientific Corp-Ongoing Clinical Trials Overview
Table 28: Ranger Drug-Coated Balloon-A Randomized Trial Comparing Drug-coated Balloon and Regular Balloon for Dialysis Access Stent Graft Restenosis
Table 29: Ranger Drug-Coated Balloon-Efficacy of Rotational Atherectomy System Associated with Drug Coated Balloon Angioplasty (with or without Stent Placement) in the Management of Lower Limb Ischemia (ELLIPSE): Real Life Observational Study
Table 30: Ranger Drug-Coated Balloon-JETStream AtheRectomy with Adjunctive Paclitaxel-coated Balloon Angioplasty Versus Balloon Angioplasty Followed by Paclitaxel-coated Balloon in Treating Complex Denovo Femoropopliteal Arterial Disease: JET-RANGER
Table 31: Ranger Drug-Coated Balloon-Prospective, Non-randomized, Multicenter Clinical Study of the Boston Scientific Paclitaxel-coated PTA Balloon Catheter (Ranger and Ranger SL (OTW) DCB) in China
Table 32: Ranger Drug-Coated Balloon-Prospective, Randomized, Multi-center Study for the Treatment of Subjects with Symptomatic Femoropopliteal Artery Disease with the Ranger Paclitaxel Coated PTA Balloon Catheter (Study Arm) Versus the IN.PACT Drug Eluting Balloon (Control Arm)
Table 33: Ranger Drug-Coated Balloon-RANGER II SFA: A 3:1 Randomized Trial Comparing the Boston Scientific RANGER Paclitaxel Coated Balloon Versus Standard Balloon Angioplasty for the Treatment of Superficial Femoral Arteries (SFA) and Proximal Popliteal Arteries (PPA)
Table 34: Cagent Vascular LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 35: Serranator Bass-Product Status
Table 36: Serranator Bass-Product Description
Table 37: Cagent Vascular LLC-Ongoing Clinical Trials Overview
Table 38: Serranator Bass-Prospective Study for the Treatment of Atherosclerotic Lesions in the Infrapopliteal Arteries Using the Serranator Device: Prelude BTK (Below The Knee) Study
Table 39: Cardiovascular Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 40: Peripheral PTA Balloon Catheter-Product Status
List of Figures
Figure 1: PTA Balloon Catheters-Pipeline Products by Stage of Development
Figure 2: PTA Balloon Catheters-Pipeline Products by Segment
Figure 3: PTA Balloon Catheters-Pipeline Products by Territory
Figure 4: PTA Balloon Catheters-Pipeline Products by Regulatory Path
Figure 5: PTA Balloon Catheters-Pipeline Products by Estimated Approval Date
Figure 6: PTA Balloon Catheters-Ongoing Clinical Trials

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Andramed GmbH
  • AnGes Inc
  • AngioCure, Inc.
  • Boston Scientific Corp
  • Cagent Vascular LLC
  • Cardiovascular Systems Inc
  • Concept Medical Inc
  • Contego Medical LLC
  • Endocor GmbH
  • eucatech AG
  • Genesis MedTech International Pvt Ltd
  • Hexacath SA
  • Lifetech Scientific (Shenzhen) Co Ltd
  • Lutonix Inc
  • M.A. Med Alliance SA
  • Medtronic Plc
  • Micell Technologies Inc
  • MicroPort Endovascular (Shanghai) Co., Ltd.
  • NuVascular Technologies Inc
  • Orchestra BioMed Inc
  • QT Vascular Ltd
  • QualiMed Innovative Medizinprodukte GmbH
  • SiL Vascular Ltd
  • Spectranetics Corp
  • SurModics Inc
  • Tailored Medical Devices Inc
  • Transit Scientific LLC
  • TransMed7 LLC
  • Vascular Nanotransfer Technologies
  • Zhejiang Zylox Medical Device Co Ltd

Related Topics

Related Reports

The Global Market for Medical Devices, 13th Edition - Product Image

The Global Market for Medical Devices, 13th Edition

  • Report
  • 312 Pages
  • Global
From
Global Drug Eluting Balloon Market by Type (Coronary Drug Eluting Balloon, Peripheral Drug Eluting Balloon), Coating Technology (EnduraCoat, FreePac, Paccocath), End User - Forecast 2023-2030 - Product Image

Global Drug Eluting Balloon Market by Type (Coronary Drug Eluting Balloon, Peripheral Drug Eluting Balloon), Coating Technology (EnduraCoat, FreePac, Paccocath), End User - Forecast 2023-2030

  • Report
  • 192 Pages
  • Global
From
PTA Balloon Catheters Pipeline Report Including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update - Product Image

PTA Balloon Catheters Pipeline Report Including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update

  • Report
  • 175 Pages
  • Global
From
PTA Peripheral DCB Catheters Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update - Product Image

PTA Peripheral DCB Catheters Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update

  • Report
  • 123 Pages
  • Global
From
PTA Balloon Catheter Global Market Report 2023 - Product Image

PTA Balloon Catheter Global Market Report 2023

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2023 Research and Markets. All Rights Reserved.